Richard D. Huhn

CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans

Gregory L. Beatty, E. Gabriela Chiorean, Matthew P. Fishman et al. · Science · 2011 · 1.6K citations

Medicine, Immunology, Oncology +17

Clinical Activity and Immune Modulation in Cancer Patients Treated With CP-870,893, a Novel CD40 Agonist Monoclonal Antibody

Robert H. Vonderheide, Keith T. Flaherty, Magi Khalil et al. · Journal of Clinical Oncology · 2007 · 513 citations

Medicine, Oncology, Pharmacology +16

Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors

Jens Rüter, Scott Antonia, Howard A. Burris et al. · Cancer Biology & Therapy · 2010 · 147 citations · Full text

Medicine, Oncology, Pharmacology +17

Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers*

Richard D. Huhn, Elaine Radwanski, Jose Gallo et al. · Clinical Pharmacology & Therapeutics · 1997 · 131 citations

Medicine, Immunology, Pharmacology +15

Stimulation of factor-dependent myeloid cell lines with interleukin 3 induces tyrosine phosphorylation of several cellular substrates.

Robert J. Isfort, Richard D. Huhn, A. Raymond Frackelton et al. · Journal of Biological Chemistry · 1988 · 116 citations · Full text

Life Sciences, Cell Biology, Cell Proliferation +14